Massively parallel Cas13 screens reveal principles for guide RNA design

Type VI CRISPR enzymes are RNA-targeting proteins with nuclease activity that enable specific and robust target gene knockdown without altering the genome. To define rules for the design of Cas13d guide RNAs (gRNAs), we conducted massively parallel screens targeting messenger RNAs (mRNAs) of a green fluorescent protein transgene, and CD46, CD55 and CD71 cell-surface proteins in human cells. In total, we measured the activity of 24,460 gRNAs with and without mismatches relative to the target sequences. Knockdown efficacy is driven by gRNA-specific features and target site context. Single mismatches generally reduce knockdown to a modest degree, but spacer nucleotides 15–21 are largely intolerant of target site mismatches. We developed a computational model to identify optimal gRNAs and confirm their generalizability, testing 3,979 guides targeting mRNAs of 48 endogenous genes. We show that Cas13 can be used in forward transcriptomic pooled screens and, using our model, predict optimized Cas13 gRNAs for all protein-coding transcripts in the human genome. Design of optimal guide RNAs for Cas13d-mediated RNA knockdown is enabled by computational modeling of large-scale screening data.

[1]  Sven Laur,et al.  Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..

[2]  Aviv Regev,et al.  RNA targeting with CRISPR–Cas13 , 2017, Nature.

[3]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[4]  Qi Chen,et al.  Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d , 2019, Nature Communications.

[5]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[6]  Lei S. Qi,et al.  CRISPR-mediated live imaging of genome editing and transcription , 2019, Science.

[7]  Dmitry Lyumkis,et al.  Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d , 2018, Cell.

[8]  Daniel Riordan,et al.  Direct capture of CRISPR guides enables scalable, multiplexed, and multi-omic Perturb-seq , 2018, bioRxiv.

[9]  Sergey A. Shmakov,et al.  Cas13b is a Type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28 , 2016, bioRxiv.

[10]  Jun Ma,et al.  The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a , 2017, Cell.

[11]  Douglas M. Anderson,et al.  Targeting Toxic Nuclear RNA Foci with CRISPR-Cas13 to Treat Myotonic Dystrophy , 2019, bioRxiv.

[12]  James J. Collins,et al.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[13]  G. Carmichael,et al.  Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 Systems. , 2019, Molecular cell.

[14]  CRISPR-Cas13d mediates robust RNA virus interference in plants , 2019, Genome Biology.

[15]  Max J. Kellner,et al.  RNA editing with CRISPR-Cas13 , 2017, Science.

[16]  Vikram Agarwal,et al.  Predicting microRNA targeting efficacy in Drosophila , 2017, Genome Biology.

[17]  L. Marraffini,et al.  RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems. , 2018, Molecular cell.

[18]  J. Darnell,et al.  Cell type-specific CLIP reveals that NOVA regulates cytoskeleton interactions in motoneurons , 2018, Genome Biology.

[19]  Peter F. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology.

[20]  Douglas M. Anderson,et al.  Targeted Cleavage and Polyadenylation of RNA by CRISPR-Cas13 , 2019, bioRxiv.

[21]  M. Reinders,et al.  A comparison of automatic cell identification methods for single-cell RNA sequencing data , 2019, Genome Biology.

[22]  A. Cheng,et al.  CRISPR artificial splicing factors , 2018, bioRxiv.

[23]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[24]  Eric S. Lander,et al.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.

[25]  C. Chiang,et al.  Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein , 2019, bioRxiv.

[26]  Aviad Tsherniak,et al.  Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration , 2018, Nature Communications.

[27]  Kira S. Makarova,et al.  Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL domain-containing accessory protein , 2018, Molecular cell.

[28]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[29]  L. Marraffini,et al.  Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage , 2019, Nature.

[30]  Ping-Chih Ho,et al.  Fifty Shades of α-Ketoglutarate on Cellular Programming. , 2019, Molecular cell.

[31]  S. Konermann,et al.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors , 2018, Cell.

[32]  Michel R. Klein,et al.  Metabolite changes in blood predict the onset of tuberculosis , 2018, Nature Communications.

[33]  Anne-Marie Alleaume,et al.  Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins , 2016, Cell reports.

[34]  Akshay Tambe,et al.  RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a. , 2018, Cell reports.

[35]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[36]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[37]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[38]  Hugues Roest Crollius,et al.  CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex , 2012, Nature Structural &Molecular Biology.

[39]  Meagan E. Sullender,et al.  Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation , 2014, Nature Biotechnology.

[40]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[41]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[42]  Hayden C. Metsky,et al.  Programmable Inhibition and Detection of RNA Viruses Using Cas13. , 2019, Molecular cell.

[43]  M. Moreno-Mateos,et al.  CRISPR-Cas13d induces efficient mRNA knock-down in animal embryos , 2020, bioRxiv.

[44]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[45]  Christopher R. Sibley,et al.  A systems view of spliceosomal assembly and branchpoints with iCLIP , 2019, Nature Structural & Molecular Biology.